BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26879601)

  • 1. BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.
    Yin G; Liu Z; Wang Y; Dou C; Li C; Yang W; Yao Y; Liu Q; Tu K
    BMC Cancer; 2016 Feb; 16():103. PubMed ID: 26879601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.
    Xu Q; Zhu Q; Zhou Z; Wang Y; Liu X; Yin G; Tong X; Tu K
    Biomed Pharmacother; 2018 Jul; 103():645-652. PubMed ID: 29679906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression.
    Feng X; Yao W; Zhang Z; Yuan F; Liang L; Zhou J; Liu S; Song J
    Oncol Res; 2018 Jul; 26(6):959-966. PubMed ID: 29295731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
    Zhao X; Tuo H; Si M; Wang L; Liang P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
    Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
    PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis.
    Gan WJ; Wang JR; Zhu XL; He XS; Guo PD; Zhang S; Li XM; Li JM; Wu H
    J Exp Clin Cancer Res; 2016 Oct; 35(1):164. PubMed ID: 27756432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
    Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
    Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
    Liu Y; Jiang P; Wang G; Liu X; Luo S
    Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
    Tu K; Zheng X; Dou C; Li C; Yang W; Yao Y; Liu Q
    Int J Mol Sci; 2014 Nov; 15(11):20486-99. PubMed ID: 25387077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.